申请人:UNIVERSITY OF CINCINNATI
公开号:US20130230542A1
公开(公告)日:2013-09-05
Provided are compounds according to the following Formula I:
The Formula I compounds are activated in the presence of reactive oxygen species (ROS) and are therefore selective anti-cancer therapeutics for cancers associated with elevated ROS. Also provided are methods and pharmaceutical compositions for treating cancers associated with increased ROS.
根据以下的公式I提供了化合物:公式I化合物在存在活性氧气体(ROS)的情况下被激活,因此对于与增加ROS相关的癌症是选择性的抗癌治疗药物。还提供了用于治疗与增加ROS相关的癌症的方法和药物组合物。